Summary & Overview
HCPCS J0735: Clonidine Hydrochloride Injection, 1 mg
HCPCS Level II code J0735 denotes a 1 mg injection of clonidine hydrochloride, an injectable formulation used in clinical settings for conditions where parenteral clonidine is indicated. Nationally, accurate coding for injectable medications like clonidine matters for clinical documentation, drug inventory management, and consistent claims submission across payers. This code captures the drug itself rather than the administration procedure.
Key payers in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of the code’s clinical context, common sites of service, and the payer landscape addressed. The publication provides benchmarks for coding and billing practices where available, summarizes any notable policy updates affecting injectable drug coding, and clarifies the distinction between drug supply codes and administration procedure codes.
The audience will gain practical clarity on when J0735 applies, how it fits into service lines that deliver injectable medications, and what documentation elements support appropriate billing. Data not provided in the input—such as specific payer fee schedules, associated ICD-10 diagnoses, and related codes—is noted as unavailable in the input.
Billing Code Overview
HCPCS Level II code J0735 represents an injection of clonidine hydrochloride, 1 mg. The service involves administration of the specified injectable medication for therapeutic purposes.
Service type: Medication administration (injectable drug)
Typical site of service: Outpatient clinic, physician office, or other ambulatory infusion/administration setting
Clinical & Coding Specifications
Clinical Context
A 62-year-old male with a history of hypertension and refractory sympathetic-mediated pain presents to an outpatient infusion clinic for a single intramuscular or subcutaneous injection of clonidine hydrochloride for blood pressure control augmentation or off-label use for severe autonomic symptoms. The order is written by his primary care physician or pain specialist after an assessment that oral therapy is inadequate or cannot be tolerated. The patient is screened for allergies, current antihypertensive medications, and orthostatic intolerance. Vital signs are obtained before and after the injection. The medication is prepared per sterile technique by a licensed nurse or pharmacist and administered in a monitored setting with post-injection observation for bradycardia, hypotension, dizziness, or sedation. Documentation includes indication, dose in milligrams, lot number, route, site of administration, consent, and any immediate adverse events. Billing uses HCPCS Level II code J0735 for clonidine hydrochloride, reported with applicable modifiers to reflect payment circumstances, provider role, or service interruptions. Typical sites of service include outpatient infusion/observation clinics, physician offices, ambulatory surgical centers when combined with other procedures, and hospital outpatient departments depending on clinical need.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
59 | Distinct procedural service |